VAL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Valaris Ltd

Watchlist Manager

Watchlist

Price: 86.57 USD 1.32% Market Closed

Market Cap: $6B

	Valaris Ltd NYSE:VAL	BM
T	Talanx AG XMUN:TLX	DE
	Klepierre SA F:KPR	FR
B	Biomarin Pharmaceutical Inc XMUN:BM8	US
W	Wells Fargo & Co XMUN:NWT	US
H	Henry Schein Inc XHAM:HS2	US
C	Celldex Therapeutics Inc SWB:TCE2	US
A	Aegon NV XHAM:AEND	NL
F	Fresenius Medical Care AG DUS:FME	DE
K	Klepierre SA SWB:KPR	FR
	Corcept Therapeutics Inc NASDAQ:CORT	US
N	NTT Data Corp F:NT5	JP
H	Halliburton Co F:HAL	US
M	Morgan Stanley XMUN:DWD	US
	Vita Coco Company Inc NASDAQ:COCO	US
S	Sandvik AB XMUN:SVKB	SE

Profitability Summary

Valaris Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Healthy Operating Margin

17%

Sustainable 3Y Average Operating Margin

13%

Operating Margin is Increasing

5% > 17%

Exceptional Net Margin

45%

Strong 3Y Average Net Margin

31%

Net Margin is Increasing

7% > 45%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-7%

Declining Free Cash Flow Margin

8% > 5%

Exceptional ROE

37%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

17%

ROIC is Increasing

4% > 23%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.